AR206792A1 - Procedimiento para la preparacion de (n-ciano-n'-alquilguanidinoetil)metilsulfoxidos - Google Patents

Procedimiento para la preparacion de (n-ciano-n'-alquilguanidinoetil)metilsulfoxidos

Info

Publication number
AR206792A1
AR206792A1 AR256332A AR25633274A AR206792A1 AR 206792 A1 AR206792 A1 AR 206792A1 AR 256332 A AR256332 A AR 256332A AR 25633274 A AR25633274 A AR 25633274A AR 206792 A1 AR206792 A1 AR 206792A1
Authority
AR
Argentina
Prior art keywords
methylsulfoxides
alkylguanidinoethyl
cyane
procedure
preparation
Prior art date
Application number
AR256332A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Application granted granted Critical
Publication of AR206792A1 publication Critical patent/AR206792A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
AR256332A 1973-02-08 1974-01-01 Procedimiento para la preparacion de (n-ciano-n'-alquilguanidinoetil)metilsulfoxidos AR206792A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB615373 1973-02-08
GB4925773A GB1421999A (en) 1973-02-08 1973-10-23 Heterocyclic containing sulphoxides

Publications (1)

Publication Number Publication Date
AR206792A1 true AR206792A1 (es) 1976-08-23

Family

ID=26240476

Family Applications (2)

Application Number Title Priority Date Filing Date
AR252233A AR207559A1 (es) 1973-02-08 1974-01-01 Procedimiento para la preparacion de (n'-alquiltioureidoetil)metilsulfoxidos heterociclicos)
AR256332A AR206792A1 (es) 1973-02-08 1974-01-01 Procedimiento para la preparacion de (n-ciano-n'-alquilguanidinoetil)metilsulfoxidos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR252233A AR207559A1 (es) 1973-02-08 1974-01-01 Procedimiento para la preparacion de (n'-alquiltioureidoetil)metilsulfoxidos heterociclicos)

Country Status (18)

Country Link
US (4) US3932443A (es)
JP (1) JPS5761740B2 (es)
AR (2) AR207559A1 (es)
AU (1) AU475265B2 (es)
CA (1) CA1018983A (es)
CH (2) CH598268A5 (es)
DE (1) DE2406166A1 (es)
EG (1) EG11468A (es)
ES (1) ES423056A1 (es)
FR (1) FR2216993B1 (es)
GB (1) GB1421999A (es)
IE (1) IE38730B1 (es)
IL (1) IL44030A (es)
IN (1) IN139091B (es)
NL (1) NL7401773A (es)
PH (1) PH10649A (es)
SE (1) SE409707B (es)
ZM (1) ZM1774A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287198A (en) * 1971-03-09 1981-09-01 Smith Kline & French Laboratories Limited Pharmacologically active guanidine compounds
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US4221802A (en) * 1972-02-03 1980-09-09 Smith Kline & French Laboratories Limited Pharmacologically active guanidine compounds for inhibiting H-2 histamine receptors
US4070475A (en) * 1972-02-03 1978-01-24 Smith Kline & French Laboratories Limited Pharmacologically active guanidine compounds as H-2 histamine receptor inhibitors
GB1421999A (en) * 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
GB1565205A (en) * 1975-07-31 1980-04-16 Smith Kline French Lab Heterocyclic sulphoxides
US4070472A (en) * 1974-02-07 1978-01-24 Smith Kline & French Laboratories Limited Guanidino, thioureido, isothioureido and nitrovinylamino derivatives of pyridine
US4090026A (en) * 1974-09-02 1978-05-16 Smith Kline & French Laboratories Limited Certain nitrogen heterocyclic isothiocyanate esters
US4151289A (en) * 1975-01-22 1979-04-24 Smith Kline & French Laboratories Limited Nitromethylene amidino derivatives containing imidazole groups
GB1574214A (en) 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
IE47044B1 (en) 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
EP0006679B1 (en) 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
US4543352A (en) * 1983-04-29 1985-09-24 William H. Rorer, Inc. Naphthalene aminoalkylene ethers and thioethers, and their pharmaceutical uses
US5166214A (en) * 1988-12-05 1992-11-24 Du Pont Merck Pharmaceutical Company Use of imidazoles for the treatment of atherosclerosis
US5179117A (en) * 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
US5310748A (en) * 1992-05-11 1994-05-10 The Du Pont Merck Pharmaceutical Company Imidazoles for the treatment of atherosclerosis
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5358946A (en) * 1992-05-29 1994-10-25 The Du Pont Merck Pharmaceutical Company Heterocycle-substituted amides, carbamates and ureas as agents for the treatment of atherosclerosis
US5883252A (en) * 1996-01-26 1999-03-16 Vertex Pharmaceuticals Incorporated Aspartyl protease inhibitors
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3808336A (en) * 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US4000296A (en) * 1972-09-05 1976-12-28 Smith Kline & French Laboratories Limited Imidazole alkylguanidine compounds
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1421999A (en) * 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
US3979398A (en) * 1973-02-08 1976-09-07 Smith Kline & French Laboratories Limited Sulphoxides
US4140783A (en) * 1976-05-24 1979-02-20 Smith Kline & French Laboratories Limited Isothiazole and isoxazole sulphoxides

Also Published As

Publication number Publication date
AU475265B2 (en) 1976-08-19
CA1018983A (en) 1977-10-11
IL44030A (en) 1979-01-31
CH601323A5 (es) 1978-07-14
PH10649A (en) 1977-07-27
EG11468A (en) 1977-11-30
ES423056A1 (es) 1976-10-01
IE38730B1 (en) 1978-05-24
NL7401773A (es) 1974-08-12
DE2406166A1 (de) 1974-08-15
FR2216993B1 (es) 1978-07-28
AR207559A1 (es) 1976-10-15
IE38730L (en) 1974-08-08
GB1421999A (en) 1976-01-21
FR2216993A1 (es) 1974-09-06
ZM1774A1 (en) 1974-09-23
JPS49102668A (es) 1974-09-27
US4338328A (en) 1982-07-06
US4255425A (en) 1981-03-10
CH598268A5 (es) 1978-04-28
SE409707B (sv) 1979-09-03
IL44030A0 (en) 1974-05-16
JPS5761740B2 (es) 1982-12-25
US4413130A (en) 1983-11-01
US3932443A (en) 1976-01-13
IN139091B (es) 1976-05-08
AU6486274A (en) 1975-07-24

Similar Documents

Publication Publication Date Title
AR206792A1 (es) Procedimiento para la preparacion de (n-ciano-n'-alquilguanidinoetil)metilsulfoxidos
AR208397A1 (es) Procedimiento para la elaboracion de compuestos de 1-piridiloxi-2-hidroxi-3-amino-propano1-piraziniloxi-2-hidroxi-3-amino-propano y 1-pirimidiniloxi-2-hidroxi-3-amino-propan
AR208527A1 (es) Procedimiento para la preparacion de 2-acil-4-oxo-polihidro-pirazino(2,1-a)isoquinolinas
AR193590A1 (es) Procedimiento para la preparacion de 2,2'-metilendifenoles sustituidos
AR204996A1 (es) Procedimiento para la preparacion de 5-metil-7-hidroxi o 7-alcoxi-isoflavonas
AR204928A1 (es) Procedimiento para la preparacion de(alquil-tioalquil)tioureas heterociclicas
MX4588E (es) Procedimiento para la preparacion de i-ariloxi-2-hidroxi-3-alquinilaminopropanos
AR204926A1 (es) Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
AR210725A1 (es) Procedimiento para la preparacion de derivados de dibenzoxepina
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR208393A1 (es) Procedimiento para la preparacion de 2,2,6,6-tetrametil-4-oxopiperidina
AR201787A1 (es) Procedimiento para la preparacion de 2(carbofenoxialquiltio) imidimidazoles
AR203188A1 (es) Procedimiento para la preparacion de derivados de tienotriazolodiacepina
AR207242A1 (es) Procedimiento de preparacion de nuevos derivados de pirazolonas-(5)-1-substituidas
AR207022A1 (es) Procedimiento para la preparacion de poli-n-dimetiliminoalano
AR206632A1 (es) Procedimiento para la preparacion de d-homoesteroides
AR201343A1 (es) Procedimiento para la preparacion de compuestos de quinoxalindiona sustituidos
IT1025664B (it) Procedimento per la preparazione di n trimetilsililacetammide
AR203196A1 (es) Procedimiento para la preparacion de derivados de imidazol-5-carboxamidoxima
AR205800A1 (es) Procedimiento para la preparacion de nuevos derivados de 3,4-difenil-imidazolina
AR213411A1 (es) Procedimiento para la preparacion de 2,6-metano-benzazocinas
AR201121A1 (es) Procedimiento para la preparacion de 2,2'-anhidro-1beta-d-arabinofuranosil-5-fluorocitosina
AR209591A1 (es) Procedimiento para la preparacion de nuecos derivados de d-4-(1'-metil-3'-oxo-1-mutenil-amino-3-isoxaz lidinona)
IT1010853B (it) Procedimento per la preparazione di 2 3 dimetilbuten i ol 3
ES550171A0 (es) Procedimiento para la preparacion de espiramicina microen- capsulada